Circ Cardiovasc Qual Outcomes

Slides:

Advertisements

Similar presentations

The Effect of Obesity on Direct Medical Costs in Total Knee Arthroplasty by Hilal Maradit Kremers, Sue L. Visscher, Walter K. Kremers, James M. Naessens,

Advertisements

Trends in Hospitalizations and Outcomes for Acute Cardiovascular Disease and Stroke, 1999–2011CLINICAL PERSPECTIVE by Harlan M. Krumholz, Sharon-Lise T.

Cumulative Radiation Exposure and Cancer Risk Estimation in Children With Heart DiseaseCLINICAL PERSPECTIVE by Jason N. Johnson, Christoph P. Hornik, Jennifer.

Early Outcomes of Tricuspid Valve Replacement in Young Children by Heather L. Bartlett, Dianne L. Atkins, Trudy L. Burns, Kelly J. Engelkes, Sarah J. Powell,

Childhood Obesity by Rajalakshmi Lakshman, Cathy E. Elks, and Ken K. Ong Circulation Volume 126(14): October 2, 2012 Copyright © American Heart.

Driving Times and Distances to Hospitals With Percutaneous Coronary Intervention in the United States by Brahmajee K. Nallamothu, Eric R. Bates, Yongfei.

Circ Cardiovasc Qual Outcomes

by Adam J. Singer, Robert H

Circ Cardiovasc Qual Outcomes

Three-dimensional Mapping of the Initiation of Nonsustained Ventricular Tachycardia in the Human Heart by Mina K. Chung, Steven M. Pogwizd, Dave P. Miller,

Relationship of Physical Activity and Body Mass Index to the Risk of Hypertension: A Prospective Study in Finland by Gang Hu, Noël C. Barengo, Jaakko Tuomilehto,

by Yehuda G. Wolf, Christopher K. Zarins, Geoffrey D

Gulf Survey of Atrial Fibrillation Events (Gulf SAFE)‏

Circ Cardiovasc Qual Outcomes

Circ Cardiovasc Interv

Atrial Fibrillation and Mortality in Heart FailureClinical Perspective

Six-month–adjusted survival after aortic valve replacement (AVR) for severe aortic stenosis (AS) stratified by procedure and preoperative ejection fraction.

CYB561 mutations. CYB561 mutations. The upper part shows the structure of the CYB561 gene, with the positions of the identified mutations indicated. Gray.

Value-Based Hypothesis Testing for Cardiac Device Clinical Trials

Circ Cardiovasc Qual Outcomes

Circ Cardiovasc Qual Outcomes

Unadjusted 3-year cumulative incidence of adverse events after saphenous vein graft (SVG) percutaneous coronary intervention (PCI) with embolic protection.

Site Selection and Performance in Clinical Trials

Circ Cardiovasc Qual Outcomes

Circ Cardiovasc Qual Outcomes

So Far, PCSK9 Inhibitors Work for All Heterozygous FH Patients

Behavior and Biology: The Basic Sciences for AHA Action

Physician and Patient Influences on Provider Performance

Circ Cardiovasc Interv

Circ Cardiovasc Qual Outcomes

by Thomas Monks, Martin Pitt, Ken Stein, and Martin James

Relative Distributions

Circ Cardiovasc Qual Outcomes

Influence of Cardiac Surgeon Report Cards on Patient Referral by Cardiologists in New York State After 20 Years of Public Reporting by David L. Brown,

Contribution of Stroke to the Cochrane Stroke Group Trials Register

Effect of Provider Volume on the Accuracy of Hospital Report Cards

Iatrogenic Adverse Events in the Coronary Care Unit

by Johan Denollet, Angélique A. Schiffer, and Viola Spek

Box plot showing percentage change in early diastolic pulsed-Doppler mitral inflow (E)/early diastolic tissue Doppler velocity (E´) from pre– to post–balloon.

Supravalvular Aortic Stenosis

Circ Cardiovasc Qual Outcomes

Circ Cardiovasc Qual Outcomes

Circ Cardiovasc Qual Outcomes

Prognostic Value of Changes in Galectin-3 Levels Over Time in Patients With Heart FailureClinical Perspective by A. Rogier van der Velde, Lars Gullestad,

Mathematical representation of Bayes theorem.

Circ Cardiovasc Qual Outcomes

Hazard ratio (HR) for mortality for a 1-kg/m2 increase in body mass index (BMI) across the range of baseline BMI among patients with acute ischemic stroke.

by Clarisse Toledo, George Thomas, Jesse D

Body Mass Index and Heart Failure Among Patients With Type 2 Diabetes MellitusCLINICAL PERSPECTIVE by Weiqin Li, Peter T. Katzmarzyk, Ronald Horswell,

Resting Ventricular–Vascular Function and Exercise Capacity in Heart Failure With Preserved Ejection FractionCLINICAL PERSPECTIVE by Selma F. Mohammed,

Arterioscler Thromb Vasc Biol

Cardiovascular Risk Factors and Sequelae in Hypertensive Children Identified by Referral Versus School-Based Screening by Jonathan M. Sorof, Jennifer Turner,

The Process of Rehabilitation and Discharge Planning in Stroke

Using the Coronary Artery Calcium Score to Guide Statin Therapy

Figure 4 BMI and mortality in patients with heart failure

Clinician Gestalt Estimate of Pretest Probability for Acute Coronary Syndrome and Pulmonary Embolism in Patients With Chest Pain and Dyspnea Jeffrey.

Eric Peterson Journal of Indian College of Cardiology

Changes in weight and body mass index (BMI) associated with quality improvement. Changes in weight and body mass index (BMI) associated with quality improvement.

Nat. Rev. Cardiol. doi: /nrcardio

Jeffrey S. Berger, et al. Circ Cardiovasc Qual Outcomes 2009;2:78-87

The volume per centre plotted against clinical outcomes which included Hospital Anxiety and Depression Scale (HADS) score, exercise 150 min, smoking, body.

The correlation between visceral fat area (VFA) and body mass index (BMI) in patients with type 2 diabetes. The correlation between visceral fat area (VFA)

Changes in clinical outcome measures over 24 months on a continuous scale in the whole SWEFOT trial population with available baseline BMI categories.

Vasiliki A. Moragianni, M. D. , M. S. , Stephanie-Marie L. Jones, M. D

Length of stay (LOS) and pre- and post-guideline trajectories.

(A) The right precordial leads V1 to V3 in a chest pain patient ultimately diagnosed with AMI. (B) Additional posterior leads V8 and V9 reveal STE, confirming.

Categorical A1c distribution within BMI categories, n=414 266 patients with T2D and available A1c data. % values represent percentage of subjects within.

Frequency of methotrexate (MTX) doses at 24 months (plot) and summary of MTX doses across the MTX dosing categories (low, medium, high) based on data at.

Associations of VO2peak to significant predictors.

Database driven calculator to support standard formulation.

Presentation transcript:

Circ Cardiovasc Qual Outcomes Association of Body Mass Index With Increased Cost of Care and Length of Stay for Emergency Department Patients With Chest Pain and Dyspnea by Geoffrey W. Peitz, Jennifer Troyer, Alan E. Jones, Nathan I. Shapiro, R. Darrell Nelson, Jackeline Hernandez, and Jeffrey A. Kline Circ Cardiovasc Qual Outcomes Volume 7(2):292-298 March 18, 2014 Copyright © American Heart Association, Inc. All rights reserved.

Median length of hospital stay (d) for each body mass index (BMI) category. Geoffrey W. Peitz et al. Circ Cardiovasc Qual Outcomes. 2014;7:292-298 Copyright © American Heart Association, Inc. All rights reserved.

Median costs (USD) for each body mass index (BMI) category. Geoffrey W. Peitz et al. Circ Cardiovasc Qual Outcomes. 2014;7:292-298 Copyright © American Heart Association, Inc. All rights reserved.

Median radiation dose (mSv) for each body mass index (BMI) category. Geoffrey W. Peitz et al. Circ Cardiovasc Qual Outcomes. 2014;7:292-298 Copyright © American Heart Association, Inc. All rights reserved.